From Sweta Killa: The Q4 earnings season has commenced and Johnson & Johnson (JNJ – Free Report) was the first drug company to report on Jan 22, before the opening bell. The world’s biggest maker of health care products continued its long streak of earnings beat and outpaced the estimate on the revenue front. However, it offered […]
The iShares Dow Jones US Pharmaceuticals Index Fund (IHE) underperformed all other non-leveraged, non-inverse exchange traded products in the U.S. today on a percentage basis, producing a -0.98% one-day return and trailing the wider markets by a total of 1.35 percentage points.
NYSE:DOW, NYSE:AGN, CVE:MSC.H
NYSEARCA:PPH, NYSEARCA:IHE
NASDAQ:MDCO, NYSE:PFE, NYSE:MRK
NYSE:PFE, NYSE:MRK, NYSE:LLY
NASDAQ:GILD, NYSE:MRK, NYSE:BMY, NYSE:ABBV
NYSE:JNJ, NYSEARCA:XLV
NASDAQ:BIIB, NYSEARCA:XPH, NYSEARCA:IHE, NYSEARCA:PJP, NYSEARCA:XLV
NYSE:JNJ, NYSEARCA:XLV
NYSEARCA:XPH, NYSEARCA:PPH
NYSE:PFE, NYSE:MRK, NASDAQ:AMGN
NYSEARCA:PJP
NYSEARCA:PPH, NYSEARCA:PJP
NYSEARCA:IWC, NYSEARCA:SDIV, NYSEARCA:IHE, NYSEARCA:IHF, NYSEARCA:PBW, NYSEARCA:AMJ